股份减持
Search documents
优刻得: 优刻得科技股份有限公司关于持股5%以上股东持股比例降至5%的权益变动提示性公告
Zheng Quan Zhi Xing· 2025-06-06 12:36
证券代码:688158 证券简称:优刻得 公告编号:2025-023 优刻得科技股份有限公司 关于持股5%以上股东持股比例降至5%的 权益变动提示性公告 经营期限 自 2016 年 11 月 09 日至 2076 年 11 月 08 日 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: ? 本次权益变动为优刻得科技股份有限公司(以下简称"公司")持股 5% 以上股东履行此前披露的股份减持计划,不触及要约收购; ? 本次权益变动后,股东中移资本控股有限责任公司(以下简称"中移资 本")持有公司股份数量由 23,537,521 股减少至 22,654,755 股,占公司目前总股 本的比例由本次减持前的 5.19%降至 5.00%; ? 本次权益变动为持股 5%以上非第一大股东减持,不会导致公司控股股 东、实际控制人发生变化。 公司于 2025 年 6 月 6 日收到股东中移资本发来的《简式权益变动报告书》, 现将其本次权益变动情况公告如下: 一、本次权益变动基本情况 (一)信息披露义务人基本情况 投资管理;资产管理; ...
隆基绿能:HHLR拟减持不超过0.50%公司股份
news flash· 2025-06-06 11:19
隆基绿能(601012)公告,截至本公告披露日,HHLR管理有限公司持有隆基绿能科技股份有限公司股 份4.16亿股,占公司总股本的5.50%。HHLR拟自公告披露之日起15个交易日后的3个月内,通过集中竞 价交易方式减持不超过3789.02万股,即不超过公司总股本的0.50%。减持期间,如公司总股本发生变 动,减持数量将相应调整。减持原因为基金投资运作需求。 ...
传艺科技实控人方套现1.37亿 2024转亏2020定增募6亿
Zhong Guo Jing Ji Wang· 2025-06-06 06:29
| 股东名称 | 咸持方式 | 减持期间 | 减持股数(股) | 占公司总股 本比例(%) | | --- | --- | --- | --- | --- | | 邹伟民 | 集中竞价 | 2025. 06. 04 | 1,112,800 | 0. 38% | | | 大宗交易 | 2025. 05. 29- | 2,223,717 | 0.77% | | 格通创投 | 集中竞价 | | 882,200 | 0. 30% | | | 大宗交易 | | 3,564,597 | 1.23% | | 陈敏 | | | - | 0. 00% | | | 合计 | | 7.783.314 | 2. 69% | 中国经济网北京6月6日讯传艺科技(002866)(002866.SZ)昨日晚间披露关于控股股东、实际控制人及其一致行动人持股比例变动触及1%及 5%整数倍暨披露简式权益变动报告书的提示性公告。 公司近日收到控股股东、实际控制人邹伟民及其一致行动人宁波格通创业投资合伙企业(有限合伙)以下简称("格通创投")出具的《简式权益 变动报告书》及《股份减持告知函》,获悉邹伟民及其一致行动人格通创投于2025年5月29日至6 ...
乖宝宠物: 中信证券股份有限公司、中泰证券股份有限公司关于乖宝宠物食品集团股份有限公司股东向特定机构投资者询价转让股份相关资格的核查意见
Zheng Quan Zhi Xing· 2025-06-05 13:25
中信证券股份有限公司、中泰证券股份有限公司 关于乖宝宠物食品集团股份有限公司股东 向特定机构投资者询价转让股份 相关资格的核查意见 中信证券股份有限公司(以下简称"中信证券")、中泰证券股份有限公司 (以下简称"中泰证券")受乖宝宠物食品集团股份有限公司(以下简称"乖宝 宠物")股东 Golden Prosperity Investment S.A.R.L.(以下简称"出让方")委托, 组织实施本次乖宝宠物首发前股东向特定机构投资者询价转让(以下简称"本次 询价转让")。 根据《上市公司股东减持股份管理暂行办法》《深圳证券交易所创业板股票 上市规则(2025 年修订)》《深圳证券交易所上市公司自律监管指引第 18 号— —股东及董事、高级管理人员减持股份(2025 年修订)》《深圳证券交易所上市 公司自律监管指引第 16 号——创业板上市公司股东询价和配售方式转让股份 (2025 年修订)》(以下简称"《询价转让和配售指引》")等相关规定,中信 证券、中泰证券对参与本次询价转让股东的相关资格进行核查,并出具本核查意 见。 一、本次询价转让的委托 中信证券、中泰证券收到出让方关于本次询价转让的委托,委托中信证券 ...
立方制药:部分董监高及股东拟减持股份
news flash· 2025-06-05 13:18
Group 1 - The company, Lifan Pharmaceutical (stock code 003020), announced that several key personnel and shareholders plan to reduce their holdings in the company [1] - Board member Wang Qing intends to reduce his holdings by no more than 321,200 shares, accounting for 0.17% of the company's total share capital [1] - Supervisor Wang Qin plans to reduce his holdings by no more than 143,400 shares, representing 0.07% of the total share capital [1] - Senior management member Dai Tianhe aims to reduce his holdings by no more than 142,900 shares, also 0.07% of the total share capital [1] - Senior management member Zheng Yong plans to reduce his holdings by no more than 104,100 shares, which is 0.05% of the total share capital [1] - Shareholder Gao Meihua intends to reduce his holdings by no more than 300,000 shares, accounting for 0.16% of the total share capital [1] Group 2 - The reduction period for these shareholdings is set from June 30, 2025, to September 29, 2025, and from June 12, 2025, to September 11, 2025 [1] - The method of reduction will be through centralized bidding or block trading [1]
四方精创:董事兼高级管理人员陈荣发拟减持0.05%公司股份
news flash· 2025-06-04 12:26
Core Viewpoint - The announcement reveals that Chen Rongfa, a director and senior executive of Sifang Jingchuang (300468), plans to reduce his shareholding in the company due to personal financial needs, involving a maximum of 276,300 shares, which represents 0.05% of the total share capital [1] Summary by Relevant Sections - **Shareholding Reduction Plan** - Chen Rongfa intends to reduce his holdings by up to 276,300 shares within three months following the announcement, through centralized bidding [1] - This reduction accounts for 0.05% of the company's total share capital [1] - **Reason for Reduction** - The reason for the share reduction is stated as personal financial needs [1] - **Source of Shares** - The shares to be reduced are sourced from the equity incentive plan granted to Chen Rongfa [1] - **Compliance and Disclosure** - Chen Rongfa will strictly adhere to relevant laws and regulations during the reduction process and will fulfill information disclosure obligations in a timely manner [1]
拓新药业实控人方套现3326万元 2021上市中天国富保荐
Zhong Guo Jing Ji Wang· 2025-06-03 03:22
Core Viewpoint - The announcement details a significant share reduction by a major shareholder of Tuoxin Pharmaceutical, indicating a shift in ownership structure and potential implications for investor confidence [1][2]. Shareholding Changes - The controlling shareholder, Yang Xining, and his concerted action party, Yiwos Trading Co., Ltd., reduced their stake by 1,019,100 shares, representing 0.81% of the total share capital [1][2]. - Post-reduction, the combined shareholding of Yang Xining and Yiwos decreased from 28.80% to 27.99% [1]. Financial Performance - Tuoxin Pharmaceutical reported a revenue of 422 million yuan for the previous year, a decline of 49.53% year-on-year [2]. - The net profit attributable to shareholders was -19.88 million yuan, compared to a profit of 243 million yuan in the previous year [2]. - The net profit after deducting non-recurring gains and losses was -27.26 million yuan, down from 23.2 million yuan year-on-year [2]. - The net cash flow from operating activities was 103 million yuan, an increase of 280.91% year-on-year [2]. Recent Quarterly Results - In the first quarter of 2025, Tuoxin Pharmaceutical achieved a revenue of 96.99 million yuan, a decrease of 10.46% compared to the same period last year [3]. - The net profit attributable to shareholders was -3.56 million yuan, compared to a profit of 0.21 million yuan in the same quarter last year [3]. - The net cash flow from operating activities was 28.01 million yuan, a decline of 153.72% year-on-year [3]. Dividend Distribution - The board approved a profit distribution plan, proposing no cash dividends or stock bonuses for shareholders [3]. Initial Public Offering (IPO) Details - Tuoxin Pharmaceutical was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on October 27, 2021, with an initial public offering of 31.5 million shares at a price of 19.11 yuan per share [3]. - The total funds raised amounted to 602 million yuan, with a net amount of 543 million yuan after deducting issuance costs [3][4]. - The funds were intended for projects related to nucleoside series specialty raw materials, pharmaceutical intermediates, and working capital [3].
青鸟消防控股股东80天套现2.33亿 2019IPO2募资共28亿
Zhong Guo Jing Ji Wang· 2025-05-30 03:42
Core Viewpoint - Qingniao Fire Protection (002960.SZ) announced the completion of its shareholder's share reduction plan, with the controlling shareholder Beijing Peking University Qingniao Huan Yu Technology Co., Ltd. reducing 20 million shares within the specified period [1] Shareholder Reduction Details - The reduction was executed through concentrated bidding and block trading methods, with the total shares reduced amounting to 2,000,000 shares, representing a 2.72% reduction of the total shares [2] - The average reduction price was 11.23 CNY per share for 700,000 shares, 12.13 CNY for 1,146,800 shares, and 10.23 CNY for 153,200 shares [2] Financial Impact - The total cash generated from the share reduction was approximately 23,338,920 CNY [3] - Qingniao Fire Protection was listed on the Shenzhen Stock Exchange on August 9, 2019, with an initial public offering of 60 million shares at a price of 17.34 CNY per share, raising a total of 104,040,000 CNY [3] - The company conducted a private placement of 74,422,182 shares on November 3, 2022, at a price of 24.01 CNY per share, raising approximately 1,786,876,589.82 CNY [3] Profit Distribution Plans - For the 2021 fiscal year, the company proposed a cash dividend of 4.0 CNY per 10 shares, totaling 139,574,244.40 CNY, along with a capital reserve conversion increasing the total shares to 488,509,855 [4] - In 2020, the company distributed 4.489534 CNY per 10 shares in cash and converted capital reserves to increase shares by 3.990697 per 10 shares [4]
北京万通新发展集团股份有限公司关于公司股东减持股份计划期限届满暨减持结果公告
Shang Hai Zheng Quan Bao· 2025-05-27 19:10
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:600246 证券简称:万通发展(维权) 公告编号:2025-046 本次股份减持计划实施前,北京万通新发展集团股份有限公司(以下简称"公司")股东和盛财富(北 京)基金管理有限公司(代表和盛财富甄选七号私募证券投资基金)(以下简称"和盛财富")持有公司 股份99,369,098股,占公司总股本的5.18%。 ● 减持计划的实施结果情况 公司于2025年2月7日披露《关于持股5%以上股东减持股份计划公告》(公告编号:2025-013)。和盛 财富拟自减持计划公告之日起15个交易日后的三个月内,且在任意连续90日内,采取集中竞价交易方式 减持股份总数不超过公司总股本的1%,即不超过19,436,400股;采取大宗交易方式减持股份总数不超过 公司总股本的2%,即不超过38,872,900股。减持价格将按照减持实施期间的市场价格确定。 公司于2025年3月1日披露《关于持股5%以上股东权益变动至5%以下的提示性公告》(公告编号:2025- 023)。和盛财富于2025年2月28日通过集中竞价交易方式减持公司股份2,187,000股,减持比例为 0.1125 ...
晚间公告丨5月27日这些公告有看头
Di Yi Cai Jing· 2025-05-27 10:40
Group 1 - Company X plans to purchase servers worth up to 4 billion yuan for providing computing power leasing services, which accounts for over 50% of its latest audited net assets and total assets, requiring shareholder approval [2] - Company Y's stock has experienced a significant increase of 46.44% over four consecutive trading days, with its cultural and creative business showing considerable unpredictability, projecting revenues of 8.868 million yuan, 5.417 million yuan, and 18.462 million yuan for the years 2022 to 2024 respectively [3] - Company Z's chairman has resigned due to personal reasons, and the vice chairman will temporarily assume the chairman's responsibilities until a new chairman is elected [4] Group 2 - Shareholder of Company A intends to reduce their stake by up to 3%, equating to a maximum of 1.6 million shares [5] - Company B's controlling shareholder has committed not to reduce their holdings from May 30, 2025, to December 31, 2025, including any shares resulting from capital increases or stock dividends during this period [6] - Company C plans to repurchase shares worth between 10 million and 20 million yuan for an employee stock ownership plan, with a maximum repurchase price of 43 yuan per share [7]